A Recent Study Looks at Long-Term Hepatitis C Recurrence Patterns

Inga Khachaturova pic
Inga Khachaturova

A fellowship-trained Orlando, Florida, physician focusing on critical care medicine, Dr. Inga Khachaturova has also completed research in hepatology. In conducting hepatological studies, Dr. Inga Khachaturova has worked to advance knowledge in a field that encompasses conditions of the liver, pancreas, gallbladder, and biliary tree.

As reported in Clinical Infectious Diseases, a recent multi-study analysis concentrated on the long-term durability of sustained virological response (SVR) among clinically treated hepatitis C (HCV) patients. Examining patients five years after treatment, the researchers found that the recurrence rate was low among patients who achieved SVR within 24 weeks of treatment.

The patients were further broken down into three groups, including low-risk mono-HCV infected patients and high-risk mono-HCV-infected patients, the latter of whom were either prisoners or users of injection drugs. The third group had experienced coinfection with HIV and HCV. Within the low-risk group, recurrence was only 108 of nearly 8,000 patients, while the higher-risk groups found recurrence in 42 of 771 patients and 31 of 309 patients, respectively. These significantly higher recurrence rates point to a need for more robust prevention campaigns aimed at high-risk patient populations.